台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    100.5
  • 漲跌
    ▼3.0
  • 漲幅
    -2.90%
  • 成交量
    1,644
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智擎 (4162)籌碼相關-宏遠-台中 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

宏遠-台中 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/2500.0011105.00104.50-111,719-0.64%
2025/03/2100.000106.00106.5001,7140.00%
2025/03/200106.5000.00106.0001,7130.00%
2025/03/1400.001104.00105.00-11,713-0.06%
2025/03/131105.008106.00103.50-71,707-0.41%
2025/03/110107.507105.50107.00-71,697-0.41%
2025/03/0700.001107.50107.50-11,665-0.06%
2025/03/062113.251111.00111.0011,6470.06%
2025/03/058115.4400.00115.5081,6450.49%
2025/03/037113.7900.00112.5071,6200.43%
2025/02/274113.505109.50109.00-11,568-0.06%
2025/02/266116.925116.30115.5011,5530.06%
2025/02/250113.0000.00113.0001,4430.00%
2025/02/2400.003114.17115.00-31,431-0.21%
2025/02/201110.0000.00110.0011,3890.07%
2025/02/170113.0000.00112.5001,3970.00%
2025/02/1400.004110.00111.50-41,408-0.28%
2025/02/130111.505111.50111.50-51,413-0.35%
2025/02/124112.0000.00112.0041,4080.28%
2025/02/111110.001111.00109.0001,3920.00%
2025/02/100119.0000.00118.5001,3370.00%
2025/02/070119.0000.00120.5001,3510.00%
2025/02/063119.003118.51119.0001,3290.00%
2025/02/053109.173110.19113.0001,1940.00%
2025/01/14096.0000.0096.1001,3720.00%
2025/01/070101.5000.00101.5001,2750.00%
2024/11/0600.001102.50102.50-1826-0.12%
2024/11/051107.0000.00106.0017820.13%
2024/11/041104.009103.39100.00-8758-1.05%
2024/11/015105.000110.00105.0057300.68%
2024/10/302100.5000.00102.0026170.32%
2024/10/291100.0000.00100.5016040.17%
2024/10/281102.001103.99102.0005760.00%
2024/10/241100.0000.0098.3014940.20%
2024/10/1800.00187.4086.80-1450-0.22%
2024/10/09190.80291.5089.50-1508-0.20%
2024/10/08291.3500.0091.1025070.39%
2024/08/0500.00183.5083.00-1764-0.13%
2024/07/19198.2000.0094.2017080.14%
2024/07/1200.00296.7095.60-2648-0.31%
2024/07/11295.9000.0095.2026500.31%
2024/07/101097.901097.5196.6006580.00%
2024/06/0700.00093.1094.5006440.00%
2024/06/06091.9000.0091.1006300.01%
2024/05/0800.00293.8094.00-21,096-0.18%
2024/04/29092.8000.0095.3001,4300.00%
2024/04/19189.0000.0089.0011,5230.07%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-26天前
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章